Evidence map›Paper›PMID 40700022›Full record

ArticleNeuropsychopharmacology reports2025

Mediators of the Association Between Severity of Noncommunicable Diseases and Subjective Health-Related Quality of Life.

Kazuyuki Nakagome, Michiyo Azechi, Teruo Noguchi, Chisato Izumi, Tsutomu Tomita, Fumihiko Yasuno, Reiko Saika, Yuji Takahashi, Hiroe Kikuchi, Maiko Fujimori and 6 more

Abstract read
In one paragraph

Article in Neuropsychopharmacology reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Kazuyuki NakagomeNational Center of Neurology and Psychiatry, Tokyo, Japan.ORCID https://orcid.org/0000-0003-2919-8180
Michiyo AzechiDepartment of Psychiatry, National Cerebral and Cardiovascular Center, Osaka, Japan.ORCID https://orcid.org/0009-0003-5158-4923
Teruo NoguchiDepartment of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Osaka, Japan.ORCID https://orcid.org/0000-0001-5372-4932
Chisato IzumiDepartment of Heart Failure and Transplantation, National Cerebral and Cardiovascular Center, Osaka, Japan.ORCID https://orcid.org/0000-0002-3282-1327
Tsutomu TomitaNCVC Biobank, National Cerebral and Cardiovascular Center, Osaka, Japan.ORCID https://orcid.org/0000-0001-5753-4255
Fumihiko YasunoDepartment of Psychiatry, National Center for Geriatrics and Gerontology, Morioka, Japan.ORCID https://orcid.org/0000-0002-5981-5795
Reiko SaikaDepartment of Neurology, National Center of Neurology and Psychiatry, Tokyo, Japan.ORCID https://orcid.org/0000-0002-7355-2581
Yuji TakahashiDepartment of Neurology, National Center of Neurology and Psychiatry, Tokyo, Japan.ORCID https://orcid.org/0000-0001-5335-7757
Hiroe KikuchiDepartment of Psychosomatic Medicine, National Center for Global Health and Medicine, Tokyo, Japan.ORCID https://orcid.org/0000-0001-5936-5950
Maiko FujimoriDivision of Survivorship Research, National Cancer Center Institute for Cancer Control, Tokyo, Japan.ORCID https://orcid.org/0000-0003-1639-3390
Yosuke UchitomiDepartment of Cancer Survivorship and Digital Medicine, The Jikei University School of Medicine, Tokyo, Japan.ORCID https://orcid.org/0009-0007-5976-2359
Yoshie OmachiDepartment of Forensic Psychiatry, National Center of Neurology and Psychiatry, Tokyo, Japan.ORCID https://orcid.org/0009-0000-0253-5031
Yasunori MorioDepartment of Clinical Research Support, Clinical Research & Education Promotion Division, National Center of Neurology and Psychiatry, Tokyo, Japan.ORCID https://orcid.org/0009-0009-7806-4577
Ryo KanzakaDepartment of Clinical Research Support, Clinical Research & Education Promotion Division, National Center of Neurology and Psychiatry, Tokyo, Japan.ORCID https://orcid.org/0000-0001-9462-4057
Mari ObaDepartment of Clinical Research Support, Clinical Research & Education Promotion Division, National Center of Neurology and Psychiatry, Tokyo, Japan.ORCID https://orcid.org/0000-0001-8374-8038
Kotaro HattoriDepartment of Bioresources, Medical Genome Center, National Center of Neurology and Psychiatry, Tokyo, Japan.ORCID https://orcid.org/0000-0002-4411-2317

Funding

Japan Health Research Promotion Bureau 2020-B-07
6 · The paper itself

Abstract

aimNoncommunicable diseases (NCDs) represent one of the greatest global burdens of disease and disability, and there is evidence that mental disorders associated with NCDs may reduce quality of life (QOL). We investigated the factors mediating the association between the severity of NCDs and subjective health-related QOL in 173 patients with NCDs.

methodsWe hypothesized that mental health indicators and inflammatory cytokines mediate the association between physical disease severity and subjective health-related QOL. We conducted a structural equation model analysis and selected variables representing mental health and inflammatory cytokines using a multivariable regression analysis and factor analysis.

resultsThe structural equation model showed that mental health indicators such as anxiety and positive emotions are potential mediators, and that proinflammatory cytokines such as interleukin-6 (IL6) and tumor necrosis factor-α (TNF-α) may reduce subjective health-related QOL by increasing anxiety and suppressing positive emotions, without being particularly related to physical disease severity. The findings also suggest that anti-inflammatory cytokines such as interleukin-10 (IL10) and adiponectin (ADPN) are activated as physical disease severity increases, and likely protect against physical disease by enhancing positive emotions, potentially increasing subjective health-related QOL and resilience.

conclusionMental health mediates the association between physical disease and subjective health-related QOL, and between inflammatory cytokines and subjective health-related QOL. Anti-inflammatory cytokines are activated by physical disease severity and have a protective effect on mental health.

Indexed as

CytokinesNoncommunicable DiseasesQuality of LifeSeverity of Illness IndexAdultAgedAnxietyFemaleHumansMaleMental HealthMiddle AgedCytokinescytokineshealth‐related quality of lifeheart failureinflammationmental health

Identifiers

PMID40700022
PMCPMC12285685

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.